DDB
Derik De Bruin B of A Securities Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
Phibro Animal Health
PAHC
$1.58B
| $39.07 | $27 |
31%
downside
| Underperform | 6 days ago |
|
2 |
2
Revvity
RVTY
$9.95B
| $85.70 | $110 |
28%
upside
| Buy | 2 months ago |
|
3 |
3
Bruker
BRKR
$4.52B
| $29.79 | $50 |
68%
upside
| Buy | 2 months ago |
|
4 |
4
10x Genomics
TXG
$1.69B
| $13.57 | $13 |
4%
downside
| Neutral | 2 months ago |
|
5 |
5
Qiagen
QGEN
$10.2B
| $47.04 | $53 |
13%
upside
| Buy | 2 months ago |
|
6 |
6
Mettler-Toledo International
MTD
$26.5B
| $1,287.79 | $1,260 |
2%
downside
| Neutral | 2 months ago |
|
7 |
7
Waters Corp
WAT
$17.8B
| $299.69 | $375 |
25%
upside
| Neutral | 2 months ago |
|
8 |
8
Agilent Technologies
A
$36.4B
| $128.48 | $128 |
0%
downside
| Neutral | 4 months ago |
|
9 |
9
Myriad Genetics
MYGN
$632M
| $6.79 | $11 |
62%
upside
| Underperform | 6 months ago |
|
10 |
10
Exact Sciences
EXAS
$9.73B
| $51.41 | $65 |
26%
upside
| Buy | 6 months ago |
|
11 |
11
NeoGenomics
NEO
$1.04B
| $8.06 | $16 |
99%
upside
| Neutral | 6 months ago |
|
12 |
12
Thermo Fisher Scientific
TMO
$185B
| $489.49 | $660 |
35%
upside
| Buy | 8 months ago |
|
13 |
13
IQVIA
IQV
$31.3B
| $184.08 | $235 |
28%
upside
| Buy | 8 months ago |
|
14 |
14
Charles River Laboratories
CRL
$7.99B
| $162.31 | $210 |
29%
upside
| Neutral | 8 months ago |
|
15 |
15
West Pharmaceutical
WST
$17.8B
| $247.54 | $355 |
43%
upside
| Buy | 8 months ago |
|
16 |
16
Stevanato
STVN
$6.29B
| $23.04 | $26 |
13%
upside
| Buy | 8 months ago |
|
17 |
17
Labcorp
LH
$22.9B
| $275.23 | $271 |
2%
downside
| Buy | 8 months ago |
|
18 |
18
Quest Diagnostics
DGX
$20.1B
| $180.11 | $182 |
1%
upside
| Buy | 8 months ago |
|
19 |
19
Danaher
DHR
$143B
| $199.03 | $290 |
46%
upside
| Buy | 8 months ago |
|
20 |
20
Fortrea Holdings
FTRE
$954M
| $10.51 | $21 |
100%
upside
| Underperform | 1 year ago |
|
21 |
21
Schrodinger
SDGR
$1.4B
| $18.97 | $32 |
69%
upside
| Neutral | 1 year ago |
|
22 |
22
Illumina
ILMN
$15.5B
| $97.68 | $100 |
2%
upside
| Underperform | 1 year ago |
|
23 |
23
Hologic
HOLX
$14.8B
| $66.39 | $86 |
30%
upside
| Neutral | 2 years ago |
|
24 |
24
Evotec
EVO
$1.2B
| $3.37 | $13 |
286%
upside
| Neutral | 2 years ago |
|
25 |
25
Icon
ICLR
$13.7B
| $176.36 | $260 |
47%
upside
| Buy | 2 years ago |
|